Transcription factor of tomato ascorbic acid biosynthetic gene and application

By activating the SlERF.B2 and/or SlERF.B5 transcription factors, the expression of SlGGP1 is regulated, and the problem of reduced ascorbic acid content in tomatoes is solved, and stress resistance and antioxidant ability are improved.

CN118909067APending Publication Date: 2024-11-08INST OF ECONOMIC CROP HUBEI ACADEMY OF AGRI SCI
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411333323.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Mutation or deletion of the rate-limiting enzyme GGP in the ascorbic acid biosynthesis pathway in tomatoes leads to a significant reduction in the content of ascorbic acid, affecting the plant's stress resistance and antioxidant ability.

Method used

SlERF.B2 and/or SlERF.B5 transcription factors were found and used to activate the expression of SlGGP1, regulate the D-Man/L-Gal pathway, increase the accumulation of ascorbic acid in tomato leaves and red-ripe fruits, and improve stress resistance.

Benefits of technology

By activating SlGGP1, the ascorbic acid content in tomatoes is significantly improved, the tolerance to oxidation and salt stress is enhanced, and the antioxidant capacity is improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909067A_ABST
    Figure CN118909067A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of tomato ascorbic acid biosynthesis, in particular to a transcription factor of a tomato ascorbic acid biosynthetic gene and application. The invention provides a transcription factor SlERF.B2 and / or SlERF.B5 capable of activating SlGGP1 (SlGGGP1), and a preparation method of the transcription factor SlERF.B2 and / or SlERF.B5. The SlERF.B2 and / or SlERF.B5 can promote the expression of SlGGP1, increase the accumulation of ascorbic acid in tomato leaves and red ripe fruits, and improve the stress resistance of tomato seedlings.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of tomato ascorbic acid biosynthesis, and in particular to a transcription factor of a tomato ascorbic acid biosynthesis gene and its application. Background Art

[0002] Ascorbic acid, also known as vitamin C, is a polyhydroxy compound that is commonly found in higher plant cells. In plants, there are four biosynthetic pathways for ascorbic acid, of which D-mannose / L-galactose (D-Man / L-Gal) is the main pathway (Wheeler et al., 1998). This pathway uses D-glucose as a precursor substrate and, after ten reactions, ultimately produces ascorbic acid. All genes in this pathway have been reported, including HK, GPI, PMI, PMM (Oesterhelt et al., 1996), GMP (Conklin et al., 1999), GME (Wolucka et al., 2001), GGP (Dowdle et al., 2007), GPP (Conklin et al., 2006), GalDH (Gatzek et al., 2002), GLDH (Tsuyoshi et al., 1998). Among them, GDP-L-galactose phosphorylase (GGP) is the first exclusive step in ascorbic acid synthesis, converting GDP-L-galactose into L-galactose-1-phosphate. There are two GGP genes in tomatoes: SlGGP1 (Solyc06g073320) and SlGGP2 (Solyc02g091510). Several studies have shown that GGP is the rate-limiting enzyme in the D-Man / L-Gal pathway and plays an important role in ascorbic acid biosynthesis (Alegre et al., 2020; Broad et al., 2019; Fenech et al., 2021). In the SlGGP1 mutant, even if other SlGGPs are expressed normally, the ascorbic acid content in tomato leaves is significantly reduced (Baldet et al., 2013). Similarly, in the two GGP-deficient EMS mutants, the ascorbic acid content in tomato fruits is significantly reduced (Alegre et al., 2020). Transient expression of genes related to the D-Man / L-Gal synthesis pathway in tobacco showed that, whether expressed alone or collectively, the ascorbic acid content increased significantly only when GGP was present (Fenech et al., 2021). Summary of the invention

[0003] The present application discovered a transcription factor SlERF.B2 and / or SlERF.B5 that can activate SlGGP1. The SlERF.B2 and / or SlERF.B5 can promote the expression of SlGGP1, thereby regulating the D-Man / L-Gal pathway, increasing the accumulation of ascorbic acid in tomato leaves and red-ripe fruits, and improving the stress resistance of tomato seedlings.

[0004] To this end, the embodiments of the present application disclose at least the following technical solutions:

[0005] In a first aspect, the embodiment discloses a transcription factor of a tomato ascorbic acid biosynthesis gene, selected from at least one of the proteins shown in SEQ ID NO:4 or SEQ ID NO:7.

[0006] In a second aspect, the embodiment discloses a dimer for regulating tomato ascorbic acid biosynthesis, wherein the dimer is formed by the protein shown in SEQ ID NO:4 and the protein shown in SEQ ID NO:7.

[0007] In some embodiments, the tomato ascorbic acid biosynthesis gene is selected from at least one of SlGGP1, SlGPI, SlDHAR and SlcAPX.

[0008] In some embodiments, the protein shown in SEQ ID NO:4 has an AP2 domain shown in SEQ ID NO:5, which is used to bind to the promoter of the tomato ascorbic acid biosynthesis gene.

[0009] In some embodiments, the protein shown in SEQ ID NO:7 has an AP2 domain shown in SEQ ID NO:5, which is used to bind to the promoter of the tomato ascorbic acid biosynthesis gene.

[0010] In some embodiments, the AP2 domain is used to bind to the promoter DRE-Core element of the tomato ascorbic acid biosynthesis gene.

[0011] In some embodiments, the DRE-Core element of the SlGGP1 promoter is GCCGAC, the DRE-Core element of the SlGPI promoter is GCCGAC, the DRE-Core element of the SlDHAR promoter is GTCGGC, and the DRE-Core element of the SlcAPX promoter is GTCGGC.

[0012] In a third aspect, the embodiments disclose a nucleic acid molecule encoding the transcription factor described in the first aspect or the second aspect.

[0013] In some embodiments, the nucleic acid molecule is selected from at least one of a DNA molecule as shown in SEQ ID NO:3, a DNA molecule as shown in SEQ ID NO:6, a DNA molecule as shown in SEQ ID NO:8, a DNA molecule as shown in SEQ ID NO:9, a DNA molecule as shown in SEQ ID NO:10, a DNA molecule as shown in SEQ ID NO:11, a DNA molecule as shown in SEQ ID NO:12, a DNA molecule as shown in SEQ ID NO:13, a DNA molecule as shown in SEQ ID NO:14, a DNA molecule as shown in SEQ ID NO:15, a DNA molecule as shown in SEQ ID NO:16, a DNA molecule as shown in SEQ ID NO:17, a DNA molecule as shown in SEQ ID NO:18, and a DNA molecule as shown in SEQ ID NO:19.

[0014] In a fourth aspect, the embodiments disclose a vector comprising the nucleic acid molecule described in the third aspect.

[0015] In a fifth aspect, the embodiment discloses a method for overexpressing tomato ascorbic acid biosynthesis genes in tomatoes. The method comprises introducing the transcription factor described in the first aspect, the dimer described in the second aspect, the nucleic acid molecule described in the third aspect, or the vector described in the fourth aspect into tomatoes.

[0016] In a sixth aspect, an embodiment discloses a method for increasing the ascorbic acid content of tomatoes, comprising introducing the transcription factor described in the first aspect, the dimer described in the second aspect, the nucleic acid molecule described in the third aspect, or the vector described in the fourth aspect into tomatoes.

[0017] In the seventh aspect, the embodiments disclose the use of the transcription factor described in the first aspect, the dimer described in the second aspect, the nucleic acid molecule described in the third aspect, or the vector described in the fourth aspect, wherein the use is selected from at least one of regulating tomato ascorbic acid biosynthesis genes, promoting tomato ascorbic acid content, improving tomato tolerance to oxidation, improving tomato tolerance to salt stress, improving tomato antioxidant capacity, and improving tomato salt tolerance. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 Statistical results of the total ascorbic acid content (Total AsA) and the ascorbic acid (Reduced AsA) content in the AC material, SIGGP1-OE-1 material and SIGGP1-OE-3 material provided in the examples.

[0019] Figure 2Phylogenetic analysis of S1ERF.B2 or S1ERF.B5 provided in the examples. Proteins in tomato: S1ERF.B2, S1ERF.B5; potato: XP_006358219.1; pepper: NP_001311615.2; tobacco: XP_016483897.1, XP_016491248.1; Arabidopsis: AT5G51190.1, AT5G47230.1, AT5G61600.1, AT4G17490.1; rice: Os04t0398000, Os04t0547600, Os08t0474000.

[0020] Figure 3 The results of the detection of transcriptional activation activity in yeast of the full-length CDS, N-terminal CDS and C-terminal CDS of SlERF.B2 or SlERF.B5 provided in the examples.

[0021] Figure 4 The yeast one-hybrid detection results of S1ERF.B2 or S1ERF.B5 and S1GGP1 promoter provided in the examples.

[0022] Figure 5 The yeast one-hybridization detection results of the truncated fragment of S1ERF.B2 and the S1GGP1 promoter provided in the examples.

[0023] Figure 6 The yeast one-hybrid detection results of the truncated fragment of SlERF.B5 and the SlGGP1 promoter provided in the examples.

[0024] Figure 7 The transient expression test results provided in the embodiment, wherein Figure 7 A is the LUC / REN ratio of the regulatory vector containing the CDS sequence of SlERF.B2 or SlERF.B5 and the reporter vector containing the SlGGP1 promoter in tobacco leaves, Figure 7 B is the result of GUS gene expression in tobacco leaves by using a regulatory vector containing the CDS sequence of SlERF.B2 or SlERF.B5 and a reporter vector containing the SlGGP1 promoter, Figure 7 C is a GUS staining image of the regulatory vector containing the CDS sequence of SlERF.B2 or SlERF.B5 and the reporter vector containing the SlGGP1 promoter in tobacco leaves.

[0025] Figure 8 The gel electrophoresis mobility test results provided in the embodiment are as follows: Figure 8 A is the electrophoresis diagram of the in vitro interaction test between SlERF.B2 and SlGGP1 promoter probe. Figure 8B is the electrophoresis diagram of the in vitro interaction test between SlERF.B5 and SlGGP1 promoter probe.

[0026] Fig. 9 A is the relative expression level of S1ERF.B2 in AC and S1ERF.B2 overexpression strains provided in the examples. S1ERF.B2 overexpression strains include B2-OE-2 and B2-OE-5. Fig. 9 B is the relative expression level of S1ERF.B5 in AC and S1ERF.B5 overexpression strains provided in the examples. S1ERF.B5 overexpression strains include B5-OE-3 and B5-OE-6.

[0027] Fig. 9 C is the target site sequence alignment of AC and S1ERF.B2 knockout strains provided in the examples, as well as the target site sequence alignment of AC and S1ERF.B5 knockout strains. S1ERF.B2 knockout strains include B2-CR-9 and B2-CR-18. S1ERF.B5 knockout strains include B5-CR-4 and B5-CR-9.

[0028] Fig. 9 D is the relative expression of SlGGP1 and SlGGP2 in the tender leaves of multiple materials provided in the examples. The materials include AC materials, SlERF.B2 overexpression strains, SlERF.B2 knockout strains, SlERF.B5 overexpression strains, and SlERF.B5 knockout strains. SlERF.B2 overexpression strains include B2-OE-2 and B2-OE-5. SlERF.B5 overexpression strains include B5-OE-3 and B5-OE-6. SlERF.B2 knockout strains include B2-CR-9 and B2-CR-18. SlERF.B5 knockout strains include B5-CR-4 and B5-CR-9.

[0029] Fig. 9 E is the relative expression of SlGGP1 and SlGGP2 in the red ripe fruits of multiple materials provided in the examples. The materials include AC materials, SlERF.B2 overexpression strains, SlERF.B2 knockout strains, SlERF.B5 overexpression strains, and SlERF.B5 knockout strains. SlERF.B2 overexpression strains include B2-OE-2 and B2-OE-5. SlERF.B5 overexpression strains include B5-OE-3 and B5-OE-6. SlERF.B2 knockout strains include B2-CR-9 and B2-CR-18. SlERF.B5 knockout strains include B5-CR-4 and B5-CR-9.

[0030] Fig. 9F is the total ascorbic acid and reduced ascorbic acid content in the tender leaves of multiple materials provided in the examples. The materials include AC materials, S1ERF.B2 overexpression strains, and S1ERF.B5 overexpression strains. S1ERF.B2 overexpression strains include B2-OE-2 and B2-OE-5. S1ERF.B5 overexpression strains include B5-OE-3 and B5-OE-6.

[0031] Fig. 9 G is the total ascorbic acid and reduced ascorbic acid content in the red ripe fruits of multiple materials provided in the examples. The materials include AC materials, S1ERF.B2 overexpression strains, and S1ERF.B5 overexpression strains. S1ERF.B2 overexpression strains include B2-OE-2 and B2-OE-5. S1ERF.B5 overexpression strains include B5-OE-3 and B5-OE-6.

[0032] Fig. 9 H is the total ascorbic acid and reduced ascorbic acid content in the tender leaves of multiple materials provided in the examples. The materials include AC materials, S1ERF.B2 knockout strains, and S1ERF.B5 knockout strains. S1ERF.B2 knockout strains include B2-CR-9 and B2-CR-18. S1ERF.B5 knockout strains include B5-CR-4 and B5-CR-9.

[0033] Fig. 9 I is the total ascorbic acid and reduced ascorbic acid content in the red ripe fruits of multiple materials provided in the examples. The materials include AC materials, S1ERF.B2 knockout strains, and S1ERF.B5 knockout strains. S1ERF.B2 knockout strains include B2-CR-9 and B2-CR-18. S1ERF.B5 knockout strains include B5-CR-4 and B5-CR-9.

[0034] Fig.10 A is the yeast one-hybrid test results of SlERF.B2 and SlERF.B5 provided in the examples with the SlGPI promoter, the upper part is the expression vector of the SlGPI promoter, and the lower part is the plate map of the single-hybrid yeast.

[0035] Fig.10 B is the yeast one-hybrid test results of S1ERF.B2 and S1ERF.B5 provided in the examples and S1DHAR promoter, respectively. The upper part is the expression vector of S1DHAR promoter, and the lower part is the plate map of single-hybrid yeast.

[0036] Fig.10 C is the yeast one-hybrid test result of S1ERF.B2 and S1ERF.B5 provided in the examples with the SlcAPX promoter, the upper part is the expression vector of the SlcAPX promoter, and the lower part is the plate map of the one-hybrid yeast.

[0037] Fig.11 The transient expression test results provided in the embodiment, wherein Fig.11 A is the LUC / REN ratio of the regulatory vector containing the CDS sequence of SlERF.B2 or SlERF.B5 and the reporter vector containing the SlGPI promoter in tobacco leaves; Fig.11 B is the LUC / REN ratio of the regulatory vector containing the CDS sequence of SlERF.B2 or SlERF.B5 and the reporter vector containing the SlDHAR promoter in tobacco leaves; Fig.11 C is the LUC / REN ratio of the regulatory vector containing the CDS sequence of SlERF.B2 or SlERF.B5 and the reporter vector containing the SlcAPX promoter in tobacco leaves.

[0038] Fig.12 The gel electrophoresis mobility test results provided in the embodiment are as follows: Fig.12 A is the gel electrophoresis migration test result of the in vitro interaction between SlERF.B2 and SlGPI provided in the embodiment, Fig.12 B is the gel electrophoresis migration test result of the in vitro interaction between S1ERF.B2 and S1DHAR provided in the embodiment, Fig.12 C is the gel electrophoresis migration test result of the in vitro interaction between SlERF.B5 and SlcAPX provided in the example.

[0039] Fig.13 DAB staining (A) and NBT staining (B) of AC, overexpression strains, and knockout strains under oxidative stress provided in the examples. S1ERF.B2 overexpression strains include B2-OE-2 and B2-OE-5. S1ERF.B5 overexpression strains include B5-OE-3 and B5-OE-6. S1ERF.B2 knockout strains include B2-CR-9 and B2-CR-18. S1ERF.B5 knockout strains include B5-CR-4 and B5-CR-9.

[0040] Fig.14 Statistical graphs of the results of leaf MDA content (A), POD activity (B) and proline content (C) of AC, overexpression strains and knockout strains under oxidative stress provided in the examples. SlERF.B2 overexpression strains include B2-OE-2 and B2-OE-5. SlERF.B5 overexpression strains include B5-OE-3 and B5-OE-6. SlERF.B2 knockout strains include B2-CR-9 and B2-CR-18. SlERF.B5 knockout strains include B5-CR-4 and B5-CR-9.

[0041] Fig.15Statistical graphs of the results of leaf MDA content (A), POD activity (B) and proline content (C) of AC, overexpression strains and knockout strains under salt stress provided in the examples. SlERF.B2 overexpression strains include B2-OE-2 and B2-OE-5. SlERF.B5 overexpression strains include B5-OE-3 and B5-OE-6. SlERF.B2 knockout strains include B2-CR-9 and B2-CR-18. SlERF.B5 knockout strains include B5-CR-4 and B5-CR-9.

[0042] Fig.16 The results of the detection of S1ERFB2 and S1ERFB5 forming dimers to enhance the expression of S1GGP1 provided in the embodiment, wherein Fig.16 A is the result of the yeast two-hybrid assay to verify the interaction between SlERF.B2 and SlERF.B5. The pGKBT7 (BD) and pGADT7 (AD) vectors of SlERF.B2 and SlERF.B5 were constructed and transformed into yeast AH109, ​​respectively. The strains were grown in SD / -Trp-Leu, SD / -Trp-Leu-His-Ade, and SD / -Trp-Leu-His-Ade medium containing different concentrations of 3-AT, and pGADT7 was transferred as a negative control. Fig.16 B is an LCI assay to verify the interaction between S1ERF.B2 and S1ERF.B5. The combinations of S1ERF.B2-NLuc+CLuc, S1ERF.B5-CLuc+NLuc and CLuc+NLu were used as negative controls. Fig.16 C is the transient expression in tobacco leaves to verify that the co-existence of SlERF.B2 / B5 can enhance the expression of SlGGP1. ProGGP1 and pGreen II 62-SK empty vector (PG) were used as negative controls. proGGP1+PG and proGGP1+SlERF.B2+SlERF.B5 were used as controls for significance analysis.

[0043] Fig.17 The qRT-PCR method provided in the embodiment detects the expression results of genes related to ascorbic acid synthesis, wherein Fig.17 A shows the expression results of genes related to ascorbic acid synthesis in leaves of AC materials, SlERF.B2 and SlERF.B5 overexpression plants and knockout plants. Fig.17 B shows the expression results of genes related to ascorbic acid synthesis in fruits of AC materials, SlERF.B2 and SlERF.B5 overexpression plants and knockout plants at the red-ripe stage. DETAILED DESCRIPTION

[0044] In order to make the purpose, technical scheme and advantages of the present application clearer, the present application is further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application. The reagents not described separately in detail in the present application are all conventional reagents and can be obtained from commercial channels; the methods not described in detail are all conventional test methods and can be obtained from the prior art.

[0045] The AC material, also known as the tomato variety Ailsa Craig, also known as wild-type tomato, was obtained from the Tomato Genetic Resource Center (TGRC, http: / / tgrc.ucdavis.edu / ) and is numbered LA2838a.

[0046] The present application found through the study of multiple gene interactions of AC materials that SlERF.B2 and SlERF.B5 can act on the promoter of ascorbic acid biosynthesis genes, activate gene transcription, promote their expression and thus promote the synthesis of ascorbic acid. The examples found that SlERF.B2 can activate the transcription of SlGGP1, SlGPI, and SlDHAR, and SlERF.B5 can activate the transcription of SlGGP1 and SlcAPX, acting on the DRE elements in the promoters of these genes, thereby promoting their expression and ascorbic acid synthesis, while improving the tolerance of tomatoes to oxidation and salt stress, and improving their antioxidant capacity and salt tolerance.

[0047] SlERF.B2 and SlERF.B5 are transcriptional activators of SlGGP1

[0048] 1. Construction of SlGGP1 overexpression vector and overexpression strain

[0049] The SlGGP1 overexpression vector is a pHells gate8 plasmid (ZY-62782, Zeye Biotechnology) cloned with the CDS sequence of SlGGP1 (SEQ ID NO: 1), wherein the CDS sequence of SlGGP1 is amplified from the cDNA of AC material by PCR.

[0050] The SlGGP1 overexpression strain was obtained by transferring the SlGGP1 overexpression vector into AC material through Agrobacterium and screening the progeny of the transformants. The SlGGP1 overexpression strains obtained by screening were SlGGP1-OE-1 and SlGGP1-OE-3.

[0051] 2. Detection of ascorbic acid content in overexpression strains

[0052] like Figure 1 As shown, the total ascorbic acid content in the ripe tomato fruits of the SlGGP1 overexpression strain increased by more than 49%, indicating that SlGGP1 plays an important role in ascorbic acid biosynthesis.

[0053] 3. cDNA library and sequencing to screen the transcriptional activators of SlGGP1

[0054] like Figure 2 As shown, the embodiment uses the Y1H method to bait the tomato cDNA library, selects the concentration of Aureobasidin a (AbA) in the culture medium to be 15 ng / ml, and finds through sequencing that SlERF.B2 (Solyc03g093560, Gene ID: 108511945, Uniprot ID: A0A3Q7FLE0) and SlERF.B5 (Solyc03g093550, Gene ID: 101267295, Uniprot ID: A0A3Q7FNS2) are both transcription activators of SlGGP1. Further comparison with the NCBI database found that Solyc03g093560 and Solyc03g093550 are both ethylene-responsive transcription factors.

[0055] The CDS of SlERF.B2 is 735 bp in length (SEQ ID NO: 3), encoding 244 amino acids (SEQ ID NO: 4), and contains an AP2 domain (SEQ ID NO: 5) for binding to DNA.

[0056] The CDS of SlERF.B5 is 726 bp in length (SEQ ID NO: 6), encoding 241 amino acids (SEQ ID NO: 7), and contains an AP2 domain (SEQ ID NO: 5) for binding to DNA.

[0057] 4. Yeast two-hybrid test

[0058] The S1ERF.B2-BD vector is a pGBKT7 plasmid (VT1638, Ubest Biotech) cloned with the CDS sequence of S1ERF.B2 (SEQ ID NO: 3), wherein the CDS sequence of S1ERF.B2 was amplified from the cDNA of AC material by PCR.

[0059] The S1ERF.B2-N-BD vector is a pGBKT7 plasmid cloned with the N-terminal CDS sequence of S1ERF.B2 (SEQ ID NO: 8), wherein the N-terminal CDS sequence of S1ERF.B2 was amplified from the cDNA of AC material by PCR.

[0060] The S1ERF.B2-C-BD vector is a pGBKT7 plasmid cloned with the C-terminal CDS sequence of S1ERF.B2 (SEQ ID NO: 9), wherein the C-terminal CDS sequence of S1ERF.B2 was amplified from the cDNA of AC material by PCR.

[0061] The S1ERF.B5-BD vector is a pGBKT7 plasmid cloned with the CDS sequence of S1ERF.B5 (SEQ ID NO: 6), wherein the CDS sequence of S1ERF.B5 was amplified from the cDNA of AC material by PCR.

[0062] The S1ERF.B5-N-BD vector is a pGBKT7 plasmid cloned with the N-terminal CDS sequence of S1ERF.B5 (SEQ ID NO: 10), wherein the N-terminal CDS sequence of S1ERF.B5 was amplified from the cDNA of AC material by PCR.

[0063] The S1ERF.B5-C-BD vector is a pGBKT7 plasmid cloned with the C-terminal CDS sequence of S1ERF.B5 (SEQ ID NO: 11), wherein the C-terminal CDS sequence of S1ERF.B5 was amplified from the cDNA of AC material by PCR.

[0064] SlERF.B2-BD vector, SlERF.B2-N-BD vector, SlERF.B2-C-BD vector, SlERF.B5-BD vector, SlERF.B5-N-BD vector, SlERF.B5-C-BD vector were respectively transformed into yeast strain Y187, and the transformed strains were cultured on selection medium (SD / -Trp, SD / -Trp-His-Ade, SD / -Trp-His-Ade+X-α-gal), and the plate colonies were detected. The BD vector was used as a negative control.

[0065] like Figure 3 As shown, yeast cells transformed with the full-length CDS or C-terminal CDS sequence of SlERF.B2 or SlERF.B5 can grow normally and appear blue, indicating that both SlERF.B2 and SlERF.B5 can activate SlGGP1 and serve as its transcriptional activator.

[0066] SlERF.B2 or SlERF.B5 can bind to the DRE-Core element of the SlGGP1 promoter

[0067] 1. Yeast one-hybrid assay of the full-length CDS fragment of SlERF.B2 or SlERF.B5 with the SlGGP1 promoter

[0068] The S1ERF.B2-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with the CDS sequence of S1ERF.B2 (SEQ ID NO: 3), wherein the CDS sequence of S1ERF.B2 was amplified from the cDNA of AC material by PCR.

[0069] The SlERF.B5-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with the CDS sequence of SlERF.B5 (SEQ ID NO: 6), wherein the CDS sequence of SlERF.B5 was amplified from the cDNA of AC material by PCR.

[0070] The SlGGP1-pAbAi vector is a pAbAi vector (LM8159, LMAI Bio) cloned with the SlGGP1 promoter (SEQ ID NO: 2) derived from AC material. The SlGGP1-pAbAi recombinant plasmid was transformed into the activated Y1H Gold yeast strain (YB140392-10, Yubo Bio) by small-scale yeast transformation to obtain the Y1H Gold yeast containing the SlGGP1 promoter.

[0071] Example SlERF.B2-AD vector and SlERF.B5-AD vector were constructed, and the SlERF.B2-AD vector and SlERF.B5-AD vector were respectively transferred into Y1H Gold yeast containing SlGGP1 promoter, and the growth of each transformed strain on the selection medium (SD / -Ura-Leu and SD / -Ura-Leu medium with different AbA concentrations) was observed. Empty AD vector was transferred into the yeast strain containing SlGGP1 promoter as a negative control.

[0072] like Figure 4 As shown, in 30ng / mlAbA SD / -Ura-Leu medium, the strain containing SlERF.B2 and SlGGP1 promoter or the strain containing SlERF.B5 and SlGGP1 promoter and the positive control strain can grow normally, while the negative control strain cannot grow normally. This indicates that both SlERF.B2 and SlERF.B5 can bind to the SlGGP1 promoter in yeast.

[0073] 2. Yeast hybrid test of truncated CDS fragments of SlERF.B2 or SlERF.B5

[0074] The S1ERF.B2-1-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with a fragment sequence of S1ERF.B2 (S1ERF.B2-1, SEQ ID NO: 12), wherein S1ERF.B2-1 is cDNA amplified from AC material by PCR.

[0075] The S1ERF.B2-2-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with a fragment sequence of S1ERF.B2 (S1ERF.B2-2, SEQ ID NO: 13), wherein S1ERF.B2-2 is cDNA amplified from AC material by PCR.

[0076] The S1ERF.B2-3-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with a fragment sequence of S1ERF.B2 (S1ERF.B2-3, SEQ ID NO: 14), wherein S1ERF.B2-3 is cDNA amplified from AC material by PCR.

[0077] The S1ERF.B2-4-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with a fragment sequence of S1ERF.B2 (S1ERF.B2-4, SEQ ID NO: 15), wherein S1ERF.B2-4 is cDNA amplified from AC material by PCR.

[0078] The S1ERF.B5-1-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with a fragment sequence of S1ERF.B5 (S1ERF.B5-1, SEQ ID NO: 16), wherein S1ERF.B5-1 is cDNA amplified from AC material by PCR.

[0079] The S1ERF.B5-2-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with a fragment sequence of S1ERF.B5 (S1ERF.B5-2, SEQ ID NO: 17), wherein S1ERF.B5-2 is cDNA amplified from AC material by PCR.

[0080] The S1ERF.B5-3-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with a fragment sequence of S1ERF.B5 (S1ERF.B5-3, SEQ ID NO: 18), wherein S1ERF.B5-3 is cDNA amplified from AC material by PCR.

[0081] The S1ERF.B5-4-AD vector is a pGADT7 vector (VT1639, Ubest Biotech) cloned with a fragment sequence of S1ERF.B5 (S1ERF.B5-4, SEQ ID NO: 19), wherein S1ERF.B5-4 is cDNA amplified from AC material by PCR.

[0082] Among them, S1ERF.B2-1, S1ERF.B2-2, S1ERF.B2-3 and S1ERF.B2-4 are truncated from the CDS sequence of S1ERF.B2 from N-terminus to C-terminus, respectively. S1ERF.B5-1, S1ERF.B5-2, S1ERF.B5-3 and S1ERF.B5-4 are truncated from the CDS sequence of S1ERF.B5 from N-terminus to C-terminus, respectively.

[0083] The SlERF.B2-AD vector, SlERF.B2-1-AD vector, SlERF.B2-2-AD vector, SlERF.B2-3-AD vector, and SlERF.B2-4-AD vector were respectively transformed into Y1H Gold yeast containing the SlGGP1 promoter, and the growth of each transformed strain on the selection medium was observed. The empty AD vector was transformed into the yeast strain containing the SlGGP1 promoter as a negative control.

[0084] The SlERF.B5-AD vector, SlERF.B5-1-AD vector, SlERF.B5-2-AD vector, SlERF.B5-3-AD vector, and SlERF.B5-4-AD vector were respectively transformed into Y1H Gold yeast containing the SlGGP1 promoter, and the growth of each transformed strain on the selection medium was observed. The empty AD vector was transformed into the yeast strain containing the SlGGP1 promoter as a negative control.

[0085] like Figure 5 and Figure 6 As shown, the strain containing CDS of SlERF.B2, the strain containing SlERF.B2-4, the strain containing CDS of SlERF.B5, and the strain containing SlERF.B5-4 can grow normally in 30ng / mlAbA SD / -Ura-Leu medium, while the other strains cannot grow. This indicates that the C-terminal sequence of CDS of SlERF.B2 is used to bind to the SlGGP1 promoter, and the C-terminal sequence of CDS of SlERF.B5 is used to bind to the SlGGP1 promoter.

[0086] 2. Tobacco transient expression test

[0087] (1) Reporting vector and regulatory vector

[0088] The reporter vector Reporter1 is a pGreenⅡ0800-LUC plasmid (QS0464, Qinsheng Biotechnology, containing LUC reporter gene) cloned with SlGGP1 promoter (SEQ ID NO: 2), wherein the SlGGP1 promoter fragment is amplified from the gDNA of AC material by PCR.

[0089] The reporter vector Reporter2 is a pMV2 plasmid (Thermo Fisher Scientific, containing a GUS reporter gene) cloned with the SlGGP1 promoter (SEQ ID NO: 2), wherein the SlGGP1 promoter is amplified from the gDNA of the AC material by PCR.

[0090] The regulatory vector Effector1 is a pGreen II 62-SK plasmid (QP1047, Qiyun Biotechnology, containing CaMV 35S promoter) cloned with the CDS of SlERF.B2 (SEQ ID NO: 3).

[0091] The regulatory vector Effector2 is a pGreen II 62-SK plasmid cloned with the CDS of SlERF.B5 (SEQ ID NO: 6).

[0092] The regulatory vector Effector3 is a pHells gate8 plasmid (ZY-62782, Zeye Biotechnology) cloned with the CDS of SlERF.B2.

[0093] The regulatory vector Effector4 is a pHells gate8 plasmid cloned with the CDS of SlERF.B5.

[0094] (2) Test and results

[0095] The reporter vector Reporter1 and the regulatory vector Effector1 were co-transformed into tobacco leaves by Agrobacterium injection, and the pGreen II 62-SK plasmid was used as a negative control, and the relative LUC activity was calculated by the LUC / REN ratio. The reporter vector Reporter1 and the regulatory vector Effector2 were co-transformed into tobacco leaves by Agrobacterium injection, and the pGreen II 62-SK plasmid was used as a negative control, and the relative LUC activity was calculated by the LUC / REN ratio.

[0096] like Figure 7 As shown in A, the LUC activity of tobacco leaves injected with Reporter1 and Effector1 Agrobacterium was higher than that of the control group, indicating that SlERF.B2 can bind to and activate the SlGGP1 promoter.

[0097] like Figure 7 As shown in A, the LUC activity of tobacco leaves injected with Reporter1 and Effector2 Agrobacterium was higher than that of the control group, indicating that SlERF.B5 can bind to and activate the SlGGP1 promoter.

[0098] The regulatory vector Effector3 and the reporter vector Reporter2 were co-transformed into tobacco leaves by Agrobacterium injection, and GUS staining and GUS gene expression were determined. The regulatory vector Effector4 and the reporter vector Reporter2 were co-transformed into tobacco leaves by Agrobacterium injection, and GUS staining and GUS gene expression were determined. The pHells gate8 plasmid was used as a negative control and was co-transformed into tobacco leaves with the reporter vector Reporter2 for GUS staining and GUS gene expression.

[0099] like Figure 7 As shown in C, tobacco leaves injected with Effector3 and Reporter2 and tobacco leaves injected with Effector4 and Reporter2 all showed blue color, while tobacco leaves injected with pHells gate8 plasmid and Reporter2 showed almost no blue color.

[0100] like Figure 7 As shown in B, compared with the control group, the expression of GUS gene in tobacco leaves injected with Effector3 and Reporter2 and tobacco leaves injected with Effector4 and Reporter2 was significantly increased.

[0101] This indicates that SlERF.B2 and SlERF.B5 can positively regulate the expression of SlGGP1 by binding to the SlGGP1 promoter.

[0102] In vitro interaction test of SlERF.B2 or SlERF.B5 binding to SlGGP1 promoter

[0103] 1. Preparation of fusion proteins and synthetic probes

[0104] The SlERF.B2 expression vector is a pET15d-MBP plasmid (Detai Biotechnology) cloned with the CDS of SlERF.B2 (SEQ ID NO: 3). The SlERF.B2 expression vector was transferred into Escherichia coli DE3 for induced expression, and purified using a His column to obtain the fusion protein SlERF.B2-MBP.

[0105] The SlERF.B5 expression vector is a pET15d-MBP plasmid (Detai Biotechnology) cloned with the CDS of SlERF.B5 (SEQ ID NO: 6). The SlERF.B5 expression vector was transferred into Escherichia coli DE3 for induced expression, and purified using a His column to obtain the fusion protein SlERF.B5-MBP.

[0106] Synthetic binding probe P1 (Tianyi Huiyuan Company, SEQ ID NO: 20),

[0107] FAM-CTATACACAAAGTAAACC GCCGAC CACTTTTACATGTTCCAGCAG, underlined is the DRE element of SlGGP1 promoter. Synthetic competitive probe P2 (Tianyi Huiyuan Company, SEQ ID NO: 21),

[0108] CTATACACAAAGTAAACC GCCGAC CACTTTTACATGTTCCAGCAG, the underlined element is the DRE element of the SlGGP1 promoter.

[0109] Synthetic mutation probe P3 (Tianyi Huiyuan Company, SEQ ID NO: 22),

[0110] FAM-CTATACACAAAGTAAACC GTTAAC CACTTTTACATGTTCCAGCAG, the underlined sequence is the DRE element mutation sequence of the SlGGP1 promoter.

[0111] 2. Gel electrophoresis migration test

[0112] The above binding probe P1, different multiples of competitive probe P2 and mutation probe P3 were mixed with the purified fusion proteins S1ERF.B2-MBP and S1ERF.B5-MBP respectively and then subjected to gel electrophoresis migration test. Figure 8 As shown, binding bands can be formed in the lanes containing the P1 probe and SlERF.B2 protein, and in the lanes containing the P1 probe and SlERF.B5 protein, and after the addition of the competitive probe P2, the binding bands gradually weakened with the increase in the competitive probe multiples, while no binding bands were observed in the lanes containing the mutant probe P3 and SlERF.B2-MBP or SlERF.B5-MBP proteins. This indicates that SlERF.B2 and SlERF.B5 can recognize and specifically bind to the DRE element of the SlGGP1 promoter.

[0113] SlERF.B2 or SlERF.B5 regulates ascorbic acid biosynthesis by modulating the expression of SlGGP1

[0114] 1. Construction of overexpression vectors and overexpression plants of SlERF.B2 and SlERF.B5

[0115] The S1ERF.B2 overexpression vector is a pHells gate8 plasmid (ZY-62782, Zeye Biotechnology) cloned with the CDS of S1ERF.B2 (SEQ ID NO: 3), wherein the CDS of S1ERF.B2 was amplified from the cDNA of AC material by PCR.

[0116] The SlERF.B5 overexpression vector is a pHells gate8 plasmid (ZY-62782, Zeye Biotechnology) cloned with the CDS of SlERF.B5 (SEQ ID NO: 6), wherein the CDS of SlERF.B5 was amplified from the cDNA of AC material by PCR.

[0117] The SlERF.B2 overexpression strain was genetically transformed into AC material by Agrobacterium-mediated SlERF.B2 overexpression vector, and positive transformants were screened to obtain overexpression materials B2-OE-2 and B2-OE-5.

[0118] The SlERF.B5 overexpression strain was genetically transformed into AC materials by Agrobacterium-mediated SlERF.B5 overexpression vector, and positive transformants were screened to obtain overexpression materials B5-OE-3 and B5-OE-6.

[0119] 2. Construction of knockout vectors and knockout strains of SlERF.B2 and SlERF.B5

[0120] The SlERF.B2 knockout vector includes a pPL-sgRNA plasmid (BioVector-PlantCas9) cloned with a guide sequence targeting SlERF.B2 (SEQ ID NO: 23) and pPL-rCas9 (BioVector-PlantCas9).

[0121] The SlERF.B5 knockout vector includes a pPL-sgRNA plasmid (BioVector-PlantCas9) cloned with a guide sequence targeting SlERF.B5 (SEQ ID NO: 24) and pPL-rCas9 (BioVector-PlantCas9).

[0122] The SlERF.B2 knockout plants were obtained by genetically transforming the SlERF.B2 knockout vector into AC materials through Agrobacterium-mediated genetic transformation, and screening positive transformants to obtain knockout materials B2-CR-9 and B2-CR-18.

[0123] The SlERF.B5 knockout plants were obtained by genetically transforming the SlERF.B5 knockout vector into AC materials through Agrobacterium-mediated genetic transformation, and screening positive transformants to obtain knockout materials B5-CR-4 and B5-CR-9.

[0124] 3. Target sequence analysis of SlERF.B2 and SlERF.B5

[0125] The genomic DNA of the SlERF.B2 knockout plants and AC materials was extracted, and PCR amplification was performed using the primer pair F20 (SEQ ID NO: 25) and R20 (SEQ ID NO: 26). The amplified products were sequenced and the target sequence of SlERF.B2 was compared.

[0126] The genomic DNA of the SlERF.B5 knockout plants and AC materials was extracted, and PCR amplification was performed using the primer pair F21 (SEQ ID NO: 27) and R21 (SEQ ID NO: 28). The amplified products were sequenced and the target sequence of SlERF.B5 was compared.

[0127] like Fig. 9 As shown in C, B2-CR-9 has a large base deletion fragment. The base of B2-CR-18 changes from "G" to "C" and there is a 5-base deletion after the target site.

[0128] like Fig. 9 As shown in C, the base of B5-CR-4 changed from "G" to "C", the base of B5-CR-9 changed from "T" to "A", and G was inserted.

[0129] 4. Detection of the expression of SlERF.B2, SlERF.B5 and SlGGP1 by RT-PCR

[0130] Total RNA was extracted from tissues (e.g., leaves, roots, stems, and fruits) of AC materials, each overexpression plant, and each knockout plant using Trizol reagent (Vazyme, Nanjing, China). RNA was reverse transcribed into complementary DNA (cDNA) using HiScript II First-Strand cDNA Synthesis Kit (Vazyme, Nanjing, China), and the expression levels of genes in these tissues were measured using a SYBR Light Cycler 480 instrument. Total RNA was extracted from wild-type, overexpression, and knockout plants, and then reverse transcribed into cDNA to determine the expression of genes related to the AsA biosynthesis pathway. Two -ΔΔCt The relative expression of genes was quantified by the Actin gene as an internal reference.

[0131] Among them, the primers for detecting the relative expression of SlERF.B2, SlERF.B5 and SlGGP1 by RT-PCR are:

[0132] SlERF.B2-F (SEQ ID NO:29):TCGCAAGCTTCTTTAATGCTAC

[0133] SlERF.B2-R (SEQ ID NO:30): CCGTTTCTCAAGTTACTCTGT

[0134] SlERF.B5-F (SEQ ID NO:31): GTAGTGCCAATGGCATCTCCA

[0135] SlERF.B5-R(SEQ ID NO:32):TTATATCATTACAAGCTGAGACAAGGG

[0136] SlGGP1-F (SEQ ID NO:33): GAAATCTGGTCTGTTCCTCTGTGA

[0137] SlGGP1-R (SEQ ID NO:34): TTCACACACCAACTCCACATTACA

[0138] Actin-F (SEQ ID NO:35):GTCCTCTCCAGCCATCCA

[0139] Actin-R(SEQ ID NO:36):ACCACTGAGCACAATGTTACC

[0140] like Fig. 9 As shown in A, the expression level of SlERF.B2 in SlERF.B2 overexpressing plants was significantly higher than that in wild-type materials. Fig. 9 As shown in B, the expression level of SlERF.B5 in SlERF.B5 overexpressing plants was significantly higher than that in wild-type materials.

[0141] like Fig. 9 As shown in D and 9E, the expression level of SlGGP1 was significantly increased in SlERF.B2 overexpression plants, while the expression level was reduced in SlERF.B2 knockout plants. The expression level of SlGGP1 was significantly increased in SlERF.B5 overexpression plants, while the expression level was reduced in SlERF.B5 knockout plants. However, the expression level of SlGGP2 remained unchanged in the overexpression plants and knockout plants. This shows that SlERF.B2 can positively regulate the expression of SlGGP1 and the biosynthesis of ascorbic acid, but has no regulatory effect on SlGGP2. SlERF.B5 can positively regulate the expression of SlGGP1 and the biosynthesis of ascorbic acid, but has no regulatory effect on SlGGP2.

[0142] 5. Ascorbic acid content detection

[0143] like Fig. 9 F and Fig. 9 G, The contents of total ascorbic acid and reduced ascorbic acid in young leaves and red-ripe fruits of SlERF.B2-overexpressing plants and SlERF.B5-overexpressing plants were significantly higher than those in AC material.

[0144] like Fig. 9 H and Fig. 9 I. The contents of total ascorbic acid and reduced ascorbic acid in young leaves and red-ripe fruits of SlERF.B2 knockout plants and SlERF.B5 knockout plants were significantly lower than those in AC material.

[0145] These results indicate that SlERF.B2 and SlERF.B5 can promote the expression of SlGGP1 in tomato leaves and red-ripe fruits, thereby increasing the ascorbic acid content. SlERF.B2 and SlERF.B5 regulate multiple genes in ascorbic acid biosynthesis

[0146] 1. Detection of ascorbic acid synthesis-related gene expression by qRT-PCR

[0147] Total RNA was extracted from tissues (e.g., leaves, roots, stems, and fruits) of AC materials, each overexpression plant, and each knockout strain using Trizol reagent (Vazyme, Nanjing, China). RNA was reverse transcribed into complementary DNA (cDNA) using HiScript II First-Strand cDNA Synthesis Kit (Vazyme, Nanjing, China), and the expression levels of genes in these tissues were measured using a SYBRLight Cycler 480 instrument. Total RNA was extracted from wild-type, overexpression, and knockout plants and then reverse transcribed into cDNA to determine the expression of genes related to the AsA biosynthesis pathway. -ΔΔCt The relative expression of genes was quantified by the Actin gene as an internal reference.

[0148] SlGPI-F (SEQ ID NO:37):TGCTCTTCAAAAGCGTGTCC

[0149] SlGPI-R(SEQ ID NO:38):CGGCAATAAGTGCTCTGTCA

[0150] SlDHAR-F(SEQ ID NO:39):CCTACCTTCGTCTCATTTCCG

[0151] SlDHAR-R(SEQ ID NO:40):TGAACAAACATTCTGCCCATT

[0152] SlcAPX-F(SEQ ID NO:41):TGGAGCCCATTAGGGAGCA

[0153] SlcAPX-R(SEQ ID NO:42):GCCAGGTGAAAGGGAACAT

[0154] like Fig.17As shown in the examples, it was found that the expression of SlGPI, SlDHAR and SlcAPX was increased in the overexpression plants, while the expression was decreased in the knockout plants. The expression pattern of SlGPI, SlDHAR and SlcAPX was similar to that of SlGGP1.

[0155] 2. Yeast one-hybrid assay

[0156] The proGPI vector is a pAbAi plasmid cloned with the promoter sequence of SlGPI (SEQ ID NO: 43), wherein the promoter sequence of SlGPI is amplified from the genomic DNA of AC material by PCR, and the gene number of SlGPI is Solyc04g076090.

[0157] The proDHAR vector is a pAbAi plasmid cloned with the promoter sequence of SlDHAR (SEQ ID NO: 44), wherein the promoter sequence of SlDHAR is amplified from the genomic DNA of AC material by PCR, and the gene number of SlDHAR is Solyc05g054760.

[0158] The procAPX vector is a pAbAi plasmid cloned with the promoter sequence of SlcAPX (SEQ ID NO: 45), wherein the promoter sequence of SlcAPX is amplified from the genomic DNA of AC material by PCR, and the gene number of SlcAPX is Solyc06g005150.

[0159] The proGPI vector, proDHAR vector and procAPX vector were respectively transferred into Y1H Gold yeast to obtain Y1H Gold yeast containing SlGPI promoter, Y1H Gold yeast containing SlDHAR promoter and Y1H Gold yeast containing SlcAPX promoter, respectively.

[0160] The above-mentioned SlERF.B2-AD and SlERF.B5-AD vectors were respectively transformed into Y1H Gold yeast containing SlGPI promoter, Y1H Gold yeast containing SlDHAR1 promoter and Y1H Gold yeast containing SlcAPX promoter. The transformants were spread on the selection medium (SD / -Ura-Leu, different concentrations of AbA SD / -Ura-Leu) and the plate colonies were observed.

[0161] like Fig.10As shown, yeast containing SlERF.B2 and SlGPI promoters can grow normally in SD / -Ura-Leu medium containing 80ng / mL AbA (gold basidin A). Yeast containing SlERF.B2 and SlDHAR promoters can grow normally in SD / -Ura-Leu medium containing 90ng / mL AbA. Yeast containing SlERF.B2 and SlcAPX promoters cannot grow normally in SD / -Ura-Leu medium containing 100ng / mL AbA. Yeast containing SlERF.B5 and SlGPI promoters cannot grow normally in SD / -Ura-Leu medium containing 80ng / mL AbA. Yeast containing SlERF.B5 and SlDHAR promoters cannot grow normally in SD / -Ura-Leu medium containing 90ng / mL AbA. Yeast containing SlERF.B5 and SlcAPX promoters can grow normally in SD / -Ura-Leu medium containing 100 ng / mL AbA.

[0162] This indicates that SlERF.B2 can bind to SlGPI and SlDHAR promoters, and SlERF.B5 can bind to SlcAPX promoter.

[0163] 3. Tobacco transient expression test

[0164] (1) Carrier and testing process

[0165] The SlGPI-0800 vector is pGreenⅡ0800-LUC cloned with the SlGPI promoter (SED ID NO: 43).

[0166] The SlDHAR-0800 vector is pGreenⅡ0800-LUC cloned with the SlDHAR promoter (SED ID NO: 44).

[0167] The SlcAPX-0800 vector is pGreenⅡ0800-LUC cloned with the SlcAPX promoter (SED ID NO: 45).

[0168] The SlGPI-0800 vector and the above-mentioned regulatory vector Effector1 (B2-62SK) were co-transformed into tobacco leaves by Agrobacterium injection, and the pGreen II62-SK plasmid was used as a negative control. The relative LUC activity was calculated by the LUC / REN ratio.

[0169] The SlDHAR-0800 vector and the above-mentioned regulatory vector Effector1 (B2-62SK) were co-transformed into tobacco leaves by Agrobacterium injection, and the pGreen II 62-SK plasmid was used as a negative control. The relative LUC activity was calculated by the LUC / REN ratio.

[0170] The SlcAPX-0800 vector and the regulatory vector Effector1 (B2-62SK) were co-transformed into tobacco leaves by Agrobacterium injection, and the pGreen II 62-SK plasmid was used as a negative control. The relative LUC activity was calculated by the LUC / REN ratio.

[0171] The SlGPI-0800 vector and the above-mentioned regulatory vector Effector2 (B5-62SK) were co-transformed into tobacco leaves by Agrobacterium injection, and the pGreen II 62-SK plasmid was used as a negative control. The relative LUC activity was calculated by the LUC / REN ratio.

[0172] The SlDHAR-0800 vector and the above-mentioned regulatory vector Effector2 (B5-62SK) were co-transformed into tobacco leaves by Agrobacterium injection, and the pGreen II 62-SK plasmid was used as a negative control. The relative LUC activity was calculated by the LUC / REN ratio.

[0173] The SlcAPX-0800 vector and the above-mentioned regulatory vector Effector2 (B5-62SK) were co-transformed into tobacco leaves by Agrobacterium injection, and the pGreen II 62-SK plasmid was used as a negative control. The relative LUC activity was calculated by the LUC / REN ratio.

[0174] (2) Test results

[0175] like Fig.11 As shown, the LUC activity of tobacco leaves injected with SlGPI-0800 vector and Effector1 Agrobacterium solution was higher than that of the negative control group, the LUC activity of tobacco leaves injected with SlDHAR-0800 vector and Effector1 Agrobacterium solution was higher than that of the negative control group, and the LUC activity of tobacco leaves injected with SlcAPX-0800 vector and Effector1 Agrobacterium solution was not significantly different from that of the negative control. This indicates that SlERF.B2 can bind to and activate the SlGPI promoter and the SlDHAR promoter.

[0176] like Fig.11As shown, the LUC activity of tobacco leaves injected with SlGPI-0800 vector and Effector2 Agrobacterium solution was not significantly different from that of the negative control, the LUC activity of tobacco leaves injected with SlDHAR-0800 vector and Effector2 Agrobacterium solution was not significantly different from that of the negative control, and the LUC activity of tobacco leaves injected with SlcAPX-0800 vector and Effector2 Agrobacterium solution was higher than that of the negative control group. This indicates that SlERF.B5 can bind to and activate the SlcAPX promoter.

[0177] 4. In vitro interaction test

[0178] In order to verify that SlERF.B2 or SlERF.B5 can regulate multiple targets, the promoter sequences of SlGPI, SlDHAR1 and SlcAPX were retrieved from the SOL Genomics database, and analyzed using the PLANTCARE database. It was found that the promoters of SlGPI, SlDHAR1 and SlcAPX all have DRE cis-elements. This test example tests the interaction between SlERF.B2 or SlERF.B5 and the DRE cis-element of the SlGPI promoter, the DRE cis-element of the SlDHAR1 promoter and the DRE cis-element of the SlcAPX promoter through in vitro interactions.

[0179] (1) Probe and test

[0180] Synthesize SlGPI promoter binding probe (Tianyi Huiyuan Company, SEQ ID NO: 46),

[0181] TCTGATTCCTTTTACCAGA GCCGAC AGAAAAAAAAATTGTTGGA, the DRE element of the SlGPI promoter is underlined.

[0182] Synthesize S1DHAR promoter binding probe (Tianyi Huiyuan Company, SEQ ID NO: 47),

[0183] CAGGCCGCCGCCGTTACGGTG GTCGGC AAAAAAAAAAAAATTGC, the DRE element of the SlDHAR promoter is underlined.

[0184] Synthesize SlcAPX promoter binding probe (Tianyi Huiyuan Company, SEQ ID NO: 48),

[0185] AGCCCCTGACCAATAAAATT GTCGGC TTTTGTTGACATTGACAG, the DRE element of the SlcAPX promoter is underlined.

[0186] Purified fusion protein SlERF.B2-MBP or fusion protein SlERF.B5-MBP were incubated with the above-mentioned various binding probes or competitive probes in vitro, and then electrophoresis was performed using non-denaturing polyacrylamide gel to observe the migration of probes on the gel and the presence of binding bands.

[0187] (2) Results

[0188] like Fig.12 , SlERF.B2-MBP was co-incubated with SlGPI promoter binding probe and SlDHAR promoter binding probe to observe binding bands, and the binding probe weakened with the increase of competition probe multiples. This shows that SlERF.B2 can bind to SlGPI promoter and SlDHAR promoter in vitro. SlERF.B5-MBP was co-incubated with SlcAPX promoter binding probe to observe binding bands, and the binding probe weakened with the increase of competition probe multiples. This shows that SlERF.B5 can bind to SlcAPX promoter in vitro.

[0189] In summary, it was shown that SlERF.B2 or SlERF.B5 could bind to multiple genes in the D-Man / L-Gal biosynthetic pathway and thus regulate ascorbic acid synthesis.

[0190] SlERF.B2 and SlERF.B5 improve stress resistance of tomato

[0191] 1. Oxidative stress test

[0192] Ascorbic acid can remove reactive oxygen species produced by biotic and abiotic stresses, thereby protecting plant cells from damage. In order to verify whether the expression of SlERF.B2 and SlERF.B5 affects the response of plants to stress, multiple overexpression strains, knockout strains and AC materials were treated with methyl viologen (MV) to simulate oxidative stress, and the leaves of these oxidative stress materials were subjected to DAB staining, NBT staining and antioxidant index detection to detect the accumulation of ROS in the leaves.

[0193] The overexpression strain, knockout strain and AC were sown and planted in a greenhouse, and the two-week-old seedlings were transplanted into round plastic pots with a diameter of 12 cm. The one-month-old seedlings were divided into two groups, one group was sprayed with 75 μmol / L methylpurpurin (MV), and the other group was sprayed with water as a control. Samples were collected for testing.

[0194] DAB staining can reflect the accumulation of hydrogen peroxide through brown shadows. Leaves treated with water and MV were immersed in 1 mg / ml DAB solution (pH = 3.8) and incubated in the dark for 12 h. Subsequently, chlorophyll was eluted in boiling water with 95% alcohol solution (Zhang et al., 2020).

[0195] NBT staining: Plants produce a variety of reactive oxygen species under biotic and abiotic stresses. NBT can be catalyzed by superoxide anions (oxygen free radicals) to produce blue or dark blue compounds. Leaves treated with water and MV were immersed in 0.1% NBT staining solution and incubated in the dark for 6 h. Chlorophyll was decolorized using a 95% alcohol solution and stored in a 50% glycerol solution (Sekulska-Nalewajko et al., 2016).

[0196] 2. Dyeing test results

[0197] Fig.13 A shows that there was almost no browning accumulation in the AC, B2 / B5-OE and B2 / B5-CR lines treated with water. However, after MV treatment, the brown color of the leaves of B2 / B5-CR was darker than that of the AC material, and the brown color of the leaves of B2 / B5-OE was lighter than that of the AC material. Fig.13 As shown in B, NBT staining was performed on AC, B2 / B5-OE and B2 / B5-CR lines. Example 2 observed blue shadows on the leaves, and the results were similar to those of DBA staining. The results of DAB and NBT staining showed that B2 / B5-OE had less ROS accumulation under MV treatment, while B2 / B5-CR had higher ROS accumulation.

[0198] 3. Antioxidant index detection

[0199] The test example also measured the malondialdehyde (MDA) content, peroxidase (POD) activity and proline content of leaves of the control and MV-treated AC, B2-OE, B2-CR, B5-OE and B5-CR lines.

[0200] Fig.14 As shown in A, in the control group, there were no significant differences in the MDA content, POD activity, and proline content of the leaves of the AC, B2-OE, B2-CR, B5-OE, and B5-CR lines. After MV treatment, the MDA content of the B2-CR and B5-CR lines increased significantly. However, the MDA content of the B2-OE and B5-OE lines did not decrease significantly compared with the wild type.

[0201] Fig.14 As shown in Figures B and 14C, the POD activity and proline content of the B2-OE and B5-OE lines were significantly increased. In contrast, the POD activity and proline content of the B2-CR and B5-CR lines were decreased.

[0202] 4. Further cultivation and treatment of oxidative stress materials

[0203] The overexpression strain, knockout strain and AC material were sown in MS medium and cultured until the shoots were 1 cm long. They were then transferred to MS medium containing 100 nm NaCl and cultured for another week. Leaf samples of the materials were collected to detect the malondialdehyde (MDA) content, peroxidase (POD) activity and proline content.

[0204] like Fig.15 As shown in A, the results showed that the MDA content of B2-OE and B5-OE strains decreased, while the MDA content of B2-CR and B5-CR strains increased significantly. Fig.15 As shown in B and 15C, the POD activity and proline content of the B2-OE and B5-OE lines were significantly increased. In contrast, the POD activity and proline content of the B2-CR and B5-CR lines were significantly decreased compared with those of the AC lines.

[0205] These results showed that the overexpression of SlERF.B2 and SlERF.B5 could enhance the scavenging ability of reactive oxygen species (ROS), indicating that overexpression of SlERF.B2 and SlERF.B5 could improve the antioxidant capacity of tomatoes.

[0206] SlERF.B2 and SlERF.B5 form a dimer to regulate SlGGP1 and ascorbic acid synthesis

[0207] The interaction between SlERF.B2 and SlERF.B5 was verified by Y2H assay. The vectors SlERF.B2-pGBKT7, SlERF.B5-pGBKT7, SlERF.B2-pGADT7, and SlERF.B5-pGADT7 were combined into yeast strain AH109, ​​and empty pGADT7 was used as negative control. Fig.16 As shown in A, the yeast strain containing SlERF.B2-pGBKT7 and SlERF.B5-pGADT7 and the yeast strain containing SlERF.B2-pGADT7 and SlERF.B5-pGBKT7 all grew normally in the medium containing 3-AT, while the other combinations could not grow normally, indicating that SlERF.B2 and SlERF.B5 can form dimers.

[0208] In addition, the localization of luciferase (LUC) was examined by expressing it in separate C-terminal (CLuc) and N-terminal (NLuc) fragments and then fusing them to SlERF.B2 and SlERF.B5, respectively. Fig.16As shown in B, co-expression of SlERF.B2-NLuc and SlERF.B5-CLuc in tobacco leaves produces fluorescence. Co-expression of SlERF.B2-NLuc and CLuc, SlERF.B5-CLuc and NLuc, and NLuc and CLuc served as negative controls. LCI experiments further demonstrated the interaction between SlERF.B2 and SlERF.B5 to form a dimer.

[0209] The SlGGP1 promoter was further transiently expressed in tobacco simultaneously with SlERF.B2 and SlERF.B5. Fig.16 As shown in Figure C, when the promoter and two transcription factors were present at the same time, LUC activity was significantly increased compared with the presence of only the promoter and a single transcription factor, indicating that SlERF.B2 and SlERF.B5 can enhance the expression of SlGGP1.

[0210] The above is only a preferred specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any changes or substitutions that can be easily conceived by any technician familiar with the technical field within the technical scope disclosed in the present application should be covered within the protection scope of the present application.

Claims

1. A transcription factor of a tomato ascorbic acid biosynthesis gene, selected from at least one of the proteins shown in SEQ ID NO: 4 or SEQ ID NO:

7.

2. The transcription factor according to claim 1, wherein the protein as shown in SEQ ID NO: 4 has an AP2 domain as shown in SEQ ID NO: 5, which is used to bind to the promoter of the tomato ascorbic acid biosynthesis gene.

3. The transcription factor according to claim 1, wherein the protein as shown in SEQ ID NO:7 has an AP2 domain as shown in SEQ ID NO:

5.

4. A dimer for regulating tomato ascorbic acid biosynthesis, wherein the dimer is formed by the protein shown in SEQ ID NO:4 and the protein shown in SEQ ID NO:

7.

5. A nucleic acid molecule encoding the transcription factor according to any one of claims 1 to 3.

6. The nucleic acid molecule according to claim 5, wherein the nucleic acid molecule is selected from at least one of the DNA molecule shown in SEQ ID NO:3, the DNA molecule of SEQ ID NO:6, the DNA molecule of SEQ ID NO:8, the DNA molecule of SEQ ID NO:9, the DNA molecule of SEQ ID NO:10, the DNA molecule of SEQ ID NO:11, the DNA molecule of SEQ ID NO:12, the DNA molecule of SEQ ID NO:13, the DNA molecule of SEQ ID NO:14, the DNA molecule of SEQ ID NO:15, the DNA molecule of SEQ ID NO:16, the DNA molecule of SEQ ID NO:17, the DNA molecule of SEQ ID NO:18, and the DNA molecule of SEQ ID NO:

19.

7. A vector comprising the nucleic acid molecule according to claim 5 or 6.

8. A method for overexpressing a tomato ascorbic acid biosynthesis gene in tomato, comprising introducing the transcription factor according to any one of claims 1 to 3, the nucleic acid molecule according to claim 5 or 6, or the vector according to claim 7 into tomato.

9. A method for increasing the ascorbic acid content of tomatoes, comprising introducing the transcription factor according to any one of claims 1 to 3, the nucleic acid molecule according to claim 5 or 6, or the vector according to claim 7 into tomatoes.

10. Use of the transcription factor according to any one of claims 1 to 3, the nucleic acid molecule according to claim 5 or 6, or the vector according to claim 7, wherein the use is selected from at least one of regulating tomato ascorbic acid biosynthesis genes, promoting tomato ascorbic acid content, improving tomato tolerance to oxidation, improving tomato tolerance to salt stress, improving tomato antioxidant capacity, and improving tomato salt tolerance.

Citation Information

Cited By

  • Application of rice blast resistance related gene OsERF128

    CN120700023A

  • Application of rice blast resistance related gene oserf128

    CN120700023B